In glioma, the level of miR-128-3p expression was dramatically attenuated in glioma clinical tissues, and miR-128-3p regulated the progression of glioma via targeting NPTX1 and activating the IRS-1/PI3K/AKT signaling pathway [12]. The gene discussed is NPTX1; the disease is glioma.